Gastro-esophageal junction (GEJ) cancer

Clinical trials for Gastro-esophageal junction (GEJ) cancer explained in plain language.

Never miss a new study

Get alerted when new Gastro-esophageal junction (GEJ) cancer trials appear

Sign up with your email to follow new studies for Gastro-esophageal junction (GEJ) cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug combo shows promise for hard-to-treat stomach cancer

Disease control Ongoing

This study tests a drug called zolbetuximab that targets a protein (CLDN18.2) found in many stomach and gastroesophageal junction tumors. The drug is given alone or with chemotherapy and/or immunotherapy to see how well it controls tumor growth. The study includes 143 adults with…

Matched conditions: GASTRO-ESOPHAGEAL JUNCTION (GEJ) CANCER

Phase 2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control

Last updated Sep 02, 2026 00:00 UTC

Gastro-esophageal junction (GEJ) cancer

Get alerted when new Gastro-esophageal junction (GEJ) cancer trials appear

New drug combo shows promise for hard-to-treat stomach cancer